Transvaginal Ultrasonography Guided Embryo Transfer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2021-03-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to evaluate the value of using transvaginal ultrasound guided embryo transfer in obese patients undergoing in vitro fertilization.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates

NCT01810601

Infertility

COMPLETED NA

Ultrasound Guidance for Embryo Transfer

NCT03851536

Infertility

COMPLETED NA

Cavity Evaluation Before Intracytoplasmic Sperm Injection

NCT04257708

Infertility

UNKNOWN

Ultrasound Guided Aspiration of Hydrosalpingeal Fluid and IVF-ET Outcomes

NCT01040351

Infertility

COMPLETED PHASE2

Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success

NCT02381821

Reproductive Techniques, Assisted

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The 800 participants with body mass index more than 30kg/m2 were randomly allocated to two groups of equal size using an automated web-based randomization system. The first group 400 patient undergoing the transabdominal-guided embryo transfer, the second group 400 patient undergoing transvaginal-guided embryo transfer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled trial

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

transabdominal ultrasound

400 obese female undergo transabdominal ultrasound guided embryo transfer

Group Type ACTIVE_COMPARATOR

transabdominal ultrasound guided embryo transfer

Intervention Type PROCEDURE

400 female with body mass index more than 30undergo transabdominal ultrasound guided embryo transfer

transvaginal group

400 obese female undergo transvaginal ultrasound guided embryo transfer

Group Type ACTIVE_COMPARATOR

transvaginal ultrasound guided embryo transfer

Intervention Type PROCEDURE

400 female with body mass index more than 30 undergo transvaginal ultrasound guided embryo transfer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transabdominal ultrasound guided embryo transfer

400 female with body mass index more than 30undergo transabdominal ultrasound guided embryo transfer

Intervention Type PROCEDURE

transvaginal ultrasound guided embryo transfer

400 female with body mass index more than 30 undergo transvaginal ultrasound guided embryo transfer

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI more than 35, good ovarian reserve, unexplained infertility more than 3 years.

Exclusion Criteria

* severe male factor of infertility,uterine factor of infertility excluded by ultrasonography and hysteroscopy ,ovarian endometrioma or patients with poly cystic ovary syndrome, obesity caused by abnormal endocrine function (thyroid or adrenal disorder)

Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No